- About bilaterals.org
- Feb-2016: New ISDS platform launched
- Sep-2004: Launch announcement
- Feb-2015: Relaunch of bilaterals.org
- Mar-2013: Relaunch of bilaterals.org
- Jun-2009: Relaunch of bilaterals.org
- Dec-2008: An update from bilaterals.org and logo design contest announcement
- Dec-2006: bilaterals.org in Spanish & French
- Sep-2006: Update from bilaterals.org
- How to participate
- Key issues
- Texts of agreements
Ranbaxy deal may help India’s entry into Japan
Financial Express | June 14, 2008
Ranbaxy deal may help India’s entry into Japan
New Delhi, Jun 13 — The Daiichi Sankyo-Ranbaxy Laboratories deal has come as a shot in the arm for India’s Comprehensive Economic Co-operation Agreement (CECA) negotiations with Japan. Indian pharma companies have been unable to break into Japan, the world’s second largest drug market, due to the country’s stringent sanitary and phytosanitary standards, technical barriers to trade (TBT) and environmental norms.
"The acquisition of Ranbaxy is arecognition of the quality of Indian drug and other pharma products bytheir Japanese counterparts. Before signing the CECA (Comprehensive Economic Cooperation Agreement), we will now aggressively push the case of our pharma sector as well as that of the chemicals, bio-tech and cosmetics sectors to ensure that Japan agrees to opening up their market for these products," a government official told FE.
Since the current Japanese standards on drugs and other pharmaceuticals products are higher than the accepted international standards, it amounts to a non-tariff barrier, the officialofficial added. India will ask Japan to bring their national standards to international levels and also ensure that there is a harmonization of SPS and TBT standards of both countries.
The government is, however, seeing the Ranbaxy deal as a bigger opportunity apart from getting a foothold in the $65 billion pharma market. In a bid to pave the way for the entry of Indian health industry into Japan, New Delhi would also pitch for relaxing the norms for movement of doctors, nurse and other health professionals from India to Japan.
Indian industry sees Japan’s drug approval procedures as stricter and time-consuming. Besides, it is also mandatory to get such products are tested in Japan itself as they do not accept products tested outside that country.
India would now demand that if the US FDA (Food and Drug Administration) has given approval to a drug, Japan must also allow it without any further testing. The government is also keeping a close watch on the deal’s impact on the Indian pharma market and if it would result in costlier drugs entering the country.
Upcoming days of action
8 Oct: mobilisation in Athens against CETA - contact
8 Oct: mobilisation in Luxembourg against CETA - contact
8-15 oct: October of resistance against TTIP and CETA in Spain - contact
15 Oct: mobilisation in Paris against CETA - contact
10-15 Oct: regional week of action against RCEP in Asia-Pacific - contact
22 Oct: mobilisation in Amsterdam against CETA - contact
27-28 Oct: mobilisation in Brussels against CETA - contact
03-05 Nov: mobilisation in Brussels against TTIP - contact
4 Nov: Continental day for democracy and against FTAs & neoliberalism in Latin America - contact
Any edits, please contact us
News from the movements
30-Sep-2016 OMAL"Frente a la velocidad y las largas distancias que plantean el TTIP y el CETA, frente a los productos kilométricos del capitalismo global, frente al poder de las finanzas y la concentración del capital, frente al consumismo depredador, necesitamos profundizar las experiencias de soberanía alimentaria, de gestión colectiva de los cuidados, de democratización de la producción, de gestión pública de los bienes comunes."
28-Sep-2016 Global Labour ColumnFor decades, labour has been fighting purely defensive battles against the neo-liberal trade and investment agenda; we lack an agenda of our own. Lost ground will not be reclaimed on what is fundamentally hostile territory, argues Peter Rossmann of the IUF.
26-Sep-2016 No al TTIP
Aprobada en Les Corts Valencianes una iniciativa para instar al Gobierno central a no autorizar la firma del Acuerdo Económico y Comercial Global (CETA)Un total de 32 ayuntamientos valencianos, que aglutinan a más de un millón de personas, han rechazado este acuerdo.
23-Sep-2016 La DiariaSuplemento especial elaborado por La Diaria, Uruguay, dedicado a los Tratados de Libre Comercio.
23-Sep-2016 TeleSurDozens of Indigenous people in Peru have been absolved of accusations that they were responsible for a massacre seven years ago that killed at least 32 people, due to intense conflict triggered by the country’s free trade agreements.
22-Sep-2016 CADTMIl est urgent de lever le silence qui entoure cette question dans notre pays et de présenter des éléments de réflexion critique et de débat sur ce sujet
21-Sep-2016 El EconomistaMiles de personas se manifestaron hoy (20-9) en el barrio europeo de Bruselas contra el TTIP y el pacto comercial ya cerrado con Canadá (conocido por CETA), aún pendiente de ratificación.
21-Sep-2016 EurActivThousands of protesters marched through Brussels to demand the European Union abandon planned transatlantic free trade deals.
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Get involved.